EARLY CONVERSION TO A CNI-FREE IMMUNOSUPPRESSION WITH SRL AFTER RENAL TX - LONGTERM DATA OF A MULTICENTER TRIAL

被引：0
|
作者：
Andrassy, Joachim [1 ]
Guba, Markus [1 ]
Habicht, Antje [2 ]
Pascher, Andreas [3 ]
Heller, Katharina [4 ]
Banas, Bernhard [5 ]
Hakenberg, Oliver [6 ]
Vogel, Thomas [7 ]
Werner, Jens [1 ]
Kauke, Teresa [1 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Univ Hosp Grosshadern, Dept Surg, Munich, Germany
[2] Lmu, Transplant Ctr, Munich, Germany
[3] Charite, Dept Surg, Campus Virchow Clin, Berlin, Germany
[4] Univ Erlangen Nurnberg, Dept Med, Div Nephrol, Erlangen, Germany
[5] Univ Med Ctr, Dept Internal Med Nephrol & Transplantat 2, Regensburg, Germany
[6] Univ Rostock, Dept Urol, Rostock, Germany
[7] Univ Munster, Dept Surg, Munster, Germany
来源：
TRANSPLANT INTERNATIONAL | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
OS161
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [31] Superior Renal Function with CNI-Free Everolimus over Standard CNI-Based Regimen: 18 Months Data from the Randomized, Multi-Center MANDELA Trial in De Novo Heart Transplant Recipients.
    Barten, M. J.
    Hirt, S. W.
    Garbade, J.
    Bara, C.
    Doesch, A.
    Knosalla, C.
    Grinninger, C.
    Stypmann, J.
    Sieder, C.
    Junge, M.
    Schulz, U.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 476 - 477
  • [32] SUPERIOR RENAL FUNCTION WITH CNI-FREE EVEROLIMUS OVER STANDARD CNI-BASED REGIMEN: 18 MONTHS DATA FROM THE RANDOMIZED, MULTI-CENTER MANDELA TRIAL IN DE NOVO HEART TRANSPLANT RECIPIENTS
    Barten, M.
    Hirt, S.
    Bara, C.
    Garbade, J.
    Doesch, A.
    Knosalla, C.
    Grinninger, C.
    Stypmann, J.
    Sieder, C.
    Junge, M.
    Schulz, U.
    TRANSPLANT INTERNATIONAL, 2018, 31 : 11 - 11
  • [33] A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation
    Watson, CJE
    Firth, J
    Williams, PF
    Bradley, JR
    Pritchard, N
    Chaudhry, A
    Smith, JC
    Palmer, CR
    Bradley, JA
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (10) : 2496 - 2503
  • [34] Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen with CNI Reduction or Elimination
    Cataneo-Davila, A.
    Zuniga-Varga, J.
    Correa-Rotter, R.
    Alberu, J.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (10) : 4138 - 4146
  • [35] CNI AVOIDANCE AND STEROID WITHDRAWAL IN RENAL TRANSPLANTATION. RESULTS AT THREE YEARS OF A PROSPECTIVE MULTICENTER RANDOMIZED TRIAL COMPARING SIROLIMUS (SRL) AND CYCLOSPORINE (CsA): THE SPIESSER STUDY
    Lebranchu, Yvon
    Etienne, Isabelle
    Toupance, Olivier
    Westeel, Pierre Francois
    de Ligny, Bruno Hurault
    Rerolle, Jean Philippe
    Thervet, Eric
    Touchard, Guy
    Moulin, Bruno
    Villemain, Florence
    Le Pogamp, Patrick
    Deteix, Patrice
    TRANSPLANT INTERNATIONAL, 2009, 22 : 244 - 244
  • [36] MANDELA Study Results at 18 Months after Heart Transplantation: Superior renal function with CNI-free everolimus over standard CNI-based regimen- a randomized, multi-center trial in de novo heart transplant recipients
    Barten, Markus J.
    Hirt, Stephan W.
    Garbade, Jens
    Bara, Christoph
    Doesch, Andreas
    Knosalla, Christoph
    Grinninger, Carola
    Stypmann, Joerg
    Sieder, Christian
    Junge, Martina
    Schulz, Uwe
    TRANSPLANTATION, 2018, 102 : S362 - S362
  • [37] Improvement of renal function in transplant patients with chronic calcineurin-inhibitor (CNI) nephrotoxicity one year after conversion to Sirolimus (SRL): Predictive value of proteinuria.
    Diekmann, F
    Budde, K
    Oppenheimer, F
    Fritsche, L
    Neumayer, HH
    Campistol, JM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 648A - 648A
  • [38] Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients
    Groetzner, J
    Kaczmarek, I
    Landwehr, P
    Mueller, M
    Daebritz, S
    Lamm, P
    Meiser, B
    Reichart, B
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 25 (03) : 333 - 341
  • [39] Patient-Reported Outcomes in a Prospective Multicenter Trial of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression Regimens in Kidney Transplantation.
    Rohan, J. M.
    Leone, J. P.
    Woodle, E. S.
    Kaufman, D.
    Shields, A. R.
    Wiseman, A.
    Matas, A. J.
    West-Thielke, P.
    King, E.
    Alloway, R. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 418 - 419
  • [40] Renal improvement after overnight conversion to calcineurin-free immunosuppression within the first year after heart transplantation: Preliminary data after maintenance therapy with everolimus
    Gude, E.
    Gullestad, L.
    Fiane, A. E.
    Grov, I.
    Arora, S.
    Geiran, O. R.
    Andreassen, A. K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S75 - S75
12345